Abiopharma

🔍 Vann Brandi C (Executive)

Company: 908 Devices Inc. (MASS)

Report Date: 2026-08-01

Detailed Transactions and Holdings:

• Acquired 5,192 shares of Common Stock (Direct)
  Date: 2026-08-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,192.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 5,192 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,385.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3

Footnotes:

• F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested.
• F2: The RSUs become vested in substantially equal annual installments over the 3 years following August 1, 2025, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date.
• F3: The RSUs become vested in substantially equal annual installments over the 3 years following August 1, 2025, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date.